Literature DB >> 21688649

[A case of lung scedosporiosis successfully treated with monitoring of plasma voriconazole concentration level].

Ryo Ogata1, Eri Hagiwara, Jun Shiihara, Takashi Ogura, Hiroshi Takahashi, Katsuhiko Kamei.   

Abstract

A 71-year-old man was referred because of fever and productive cough. His chest radiograph showed a large cavitary mass with an intracavitary mycetoma-like lesion in the left middle lung field. We undertook bronchoscopy and CT-guided biopsy, and both bronchial lavage fluid culture and CT-guided biopsy culture revealed Scedosporium apiospermum. On a diagnosis of lung scedosporiosis, he was treated with 200 mg/day voriconazole for 2 months, but his symptoms did not improve. Measurement of the plasma voriconazole level showed low plasma concentration levels (peak level: 2.15 microg/ml, trough level: 0.72 microg/ml). We then increased the voriconazole dosage from 200 mg/day to 400 mg/day. After that, his symptoms and chest radiograph findings improved immediately, accompanied by an elevated plasma voriconazole level (peak level: 5.13 microg/ml, trough level: 3.13 microg/ml). We believe that measurement of plasma voriconazole levels is useful to determine its dosage in lung scedosporiosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21688649

Source DB:  PubMed          Journal:  Nihon Kokyuki Gakkai Zasshi        ISSN: 1343-3490


  4 in total

Review 1.  Pulmonary scedosporiosis mimicking aspergilloma in an immunocompetent host: a case report and review of the literature.

Authors:  Fasih Ur Rahman; Muhammad Irfan; Naima Fasih; Kauser Jabeen; Hasanat Sharif
Journal:  Infection       Date:  2015-09-09       Impact factor: 3.553

2.  The Effective Treatment of Lung Infection Due to Scedosporium prolificans with Voriconazole and Surgery.

Authors:  Seiya Masukane; Yoshihiro Kitahara; Joe Okumoto; Keisuke Sasaki; Kikuo Nakano
Journal:  Intern Med       Date:  2017-04-15       Impact factor: 1.271

3.  Scedosporium spp lung infection in immunocompetent patients: A systematic review and MOOSE-compliant meta-analysis.

Authors:  Wei Liu; Rui-Zhi Feng; Hong-Li Jiang
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.817

4.  Utilization of voriconazole drug monitoring in the treatment of cutaneous Scedosporium apiospermum infection.

Authors:  McKenna E Boyd; Harry Dao; Jerry D Estep; Yve T Huttenbach; Vagish Hemmige
Journal:  Med Mycol Case Rep       Date:  2018-09-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.